Abacus Life Reports Strong Q3 2025 Earnings Growth

Abacus Life ( (ABL) ) has shared an update.

On November 6, 2025, Abacus Global Management reported its third-quarter 2025 results, marking the tenth consecutive quarter of earnings growth. The company achieved a record revenue growth of 124% year-over-year, reaching $63.0 million, and increased its adjusted net income by 60% to $23.6 million. Abacus also completed the strategic acquisition of AccuQuote and announced a $50 million securitized asset-backed rated note, enhancing its financial services platform and creating a scalable funding mechanism. These achievements have reinforced the company’s momentum and visibility in the market, with an increased full-year 2025 outlook for adjusted net income growth between 72% and 81%.

The most recent analyst rating on (ABL) stock is a Buy with a $13.50 price target. To see the full list of analyst forecasts on Abacus Life stock, see the ABL Stock Forecast page.

Spark’s Take on ABL Stock

According to Spark, TipRanks’ AI Analyst, ABL is a Neutral.

Abacus Life’s overall stock score is driven by strong earnings call performance and revenue growth. However, significant challenges in profitability, cash flow, and technical indicators weigh heavily on the score. The negative P/E ratio and lack of dividend yield further impact the valuation negatively.

To see Spark’s full report on ABL stock, click here.

More about Abacus Life

Abacus Global Management, Inc. is a leader in the alternative asset management industry, focusing on longevity-based assets that are uncorrelated to traditional markets. The company is known for its Life Solutions and Longevity Funds segments, and it has recently expanded its asset management capabilities through strategic acquisitions.

Average Trading Volume: 765,087

Technical Sentiment Signal: Sell

Current Market Cap: $487.7M

See more insights into ABL stock on TipRanks’ Stock Analysis page.